Cabot Corporation $CBT Shares Bought by Paradiem LLC

Paradiem LLC grew its holdings in Cabot Corporation (NYSE:CBT) by 65.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 149,097 shares of the specialty chemicals company’s stock after purchasing an additional 59,030 shares during the quarter. Cabot comprises approximately 2.6% of Paradiem LLC’s portfolio, making the stock its 24th largest holding. Paradiem LLC owned approximately 0.28% of Cabot worth $11,339,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Elevation Point Wealth Partners LLC purchased a new position in Cabot during the second quarter worth approximately $28,000. Parkside Financial Bank & Trust increased its stake in shares of Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 189 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 364 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Cabot by 52.4% during the 2nd quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock valued at $55,000 after acquiring an additional 251 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in Cabot by 344.3% during the second quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock worth $61,000 after purchasing an additional 630 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CBT has been the topic of several recent analyst reports. JPMorgan Chase & Co. decreased their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. Zacks Research cut Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Mizuho raised their target price on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. UBS Group reduced their target price on Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $66.33.

Cabot Stock Up 0.6%

NYSE:CBT opened at $66.54 on Friday. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $93.24. The stock’s fifty day moving average is $65.17 and its two-hundred day moving average is $72.67. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 11.07, a price-to-earnings-growth ratio of 3.48 and a beta of 0.90. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. During the same period in the previous year, the firm posted $1.80 earnings per share. The company’s quarterly revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts anticipate that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, November 28th. This represents a $1.80 annualized dividend and a dividend yield of 2.7%. Cabot’s dividend payout ratio (DPR) is presently 29.95%.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.